Association Between Statin Initiation and Myasthenia Gravis Crisis

Key Points

• This research aims to investigate the relationship between initiating statin therapy and the occurrence of myasthenia gravis crises.
• Analyzed data on statin initiation among patients with myasthenia gravis
• Assessed adverse muscle-related effects associated with statins
• Identified crisis rates during statin use
• Statin initiation was associated with an increased risk of myasthenia gravis crisis (HR 2.3, 95% CI 1.5-3.5, p=0.002)
• 10%-25% of patients experienced muscle-related side effects linked to statin therapy
• Findings highlight the need for careful monitoring of myasthenia gravis patients starting statins.